BackEvogene Overview

Evogene Current Cash

Evogene's current cash is $8.5M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$8.54M
13.98% YoYΔ $1.05M vs prior year quarter

Peer average

Loading

Evogene Current Cash History

Loading

Evogene vs. peers: Current Cash Comparison

Loading

Evogene Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Evogene (EVGN) FAQ

Evogene (EVGN) currently reports a current cash of $8.5M as of March 2026. That compares with $7.5M in the prior-year period — up 14.0% year over year. Use the charts on this page to explore Evogene's current cash history and peer comparisons.

Evogene's current cash increased from $7.5M to $8.5M — a 14.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evogene reported $8.5M in current cash as of March 2026. That compares with $7.5M in the prior-year period — up 14.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $8.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evogene, and consider following EVGN for alerts when major investors trade the stock.

Evogene is classified in the Materials sector. On current cash, it currently shows $8.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing EVGN with unrelated industries.